Evolutionary predictability of genetic versus nongenetic resistance to anticancer drugs in melanoma
Oskar Marín-Béjar, Aljosja Rogiers, Michael Dewaele, Julia Femel, Panagiotis Karras, Joanna Poźniak, Greet Bervoets, Nina Van Raemdonck, Dennis Pedri, Toon Swings, Jonas Demeulemeester, Sara Vander Borght, Stefan Lehnert, Francesca M. Bosisio, Joost J. van den Oord, Isabelle Vanden Bempt, Diether Lambrechts, Thierry Voet, Oliver Bechter, Helen Rizos, Mitchell P. Levesque, Eleonora Leucci, Amanda W. Lund, Florian Rambow, Jean‐Christophe Marine
Topics & Concepts
BiologyCancer researchPopulationMelanomaProtein kinase BDrug resistanceSignal transductionTargeted therapyCell biologyGeneticsCancerMedicineEnvironmental healthMelanoma and MAPK PathwaysProtein Degradation and InhibitorsImmunotherapy and Immune Responses